Bamifylline hydrochloride

This classification denotes a bronchodilator with the molecular formula C20H27N5O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66466QLM3S, chemically known as 1h-purine-2,6-dione, 7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-, monohydrochloride but more generally known as bamifylline hydrochloride, which bears US NIH Compound Identifier 68549. The base compound, Bamifylline, most often comes in base and hydrochloride forms. European Medicines Agency schedules Bamifylline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12981MIG. Most nations, for tariff and trade purposes, schedule bamifylline hydrochloride under HS 29395900 and SITC 54145. As of Q4 2014, BAMIFYLLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Bamifylline hydrochloride bears US NLM identifiers UMLS ID C0771398 and NCI Concept Code C76574. SMILES: CCN(CCN1C(NC2C1C(=O)N(C(=O)N2C)C)CC3CCCCC3)CCO.CL.